Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;28(11):1483-1485.
doi: 10.1038/s41431-020-00710-y. Epub 2020 Aug 13.

Reply to Kratz et al

Thierry Frebourg  1 , Svetlana Bajalica Lagercrantz  2 , Carla Oliveira  3 , Rita Magenheim  4 , D Gareth Evans  5   6 ; European Reference Network GENTURIS
Collaborators, Affiliations
Comment

Reply to Kratz et al

Thierry Frebourg et al. Eur J Hum Genet. 2020 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Comment on

References

    1. Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res. 2018;23:e38–45. doi: 10.1158/1078-0432.CCR-17-0408. - DOI - PubMed
    1. Frebourg T, Bajalica Lagercrantz S, Oliveira C, Magenheim R, Evans DG. European Reference Network GENTURIS. Guidelines for the Li-Fraumeni and heritable TP53-related cancer syndromes. Eur J Hum Genet. 2020. 10.1038/s41431-020-0638-4. - PMC - PubMed
    1. Mirabello L, Yeager M, Mai PL, Gastier-Foster JM, Gorlick R, Khanna C, et al. Germline TP53 variants and susceptibility to osteosarcoma. J Natl Cancer Inst. 2015;107:djv101. doi: 10.1093/jnci/djv101. - DOI - PMC - PubMed
    1. Mai PL, Best AF, Peters JA, DeCastro RM, Khincha PP, Loud JT, et al. Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort. Cancer. 2016;122:3673–81.. doi: 10.1002/cncr.30248. - DOI - PMC - PubMed
    1. Amadou A, Waddington Achatz MI, Hainaut P. Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome. Curr Opin Oncol. 2018;30:23–9. doi: 10.1097/CCO.0000000000000423. - DOI - PubMed

Substances